Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions

References

• Akbane T, Tanaka K, Irie M, et al. (2011). Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans. Xenobiotica 41:372–84
   PubMed Web of Science ®Google Scholar
• Barr TJ, Jones PJ. (2011). Inhibition of human liver aldehyde oxidase: implications for potential drug--drug interactions. Drug Metab Dispos 39:2381–6
   PubMed Web of Science ®Google Scholar
• Benedetti MS, Whomsley R, Baltes E. (2006). Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opin Drug Metab Toxicol 2:895–921
   PubMed Web of Science ®Google Scholar
• Busby WF Jr, Ackermann JM, Crespi CL. (1999). Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab Dispos 27:246–9
   PubMed Web of Science ®Google Scholar
• Clarke SE, Harrell AW, Chenery RJ. (1995). Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. Drug Metab Dispos 23:251–4
   PubMed Web of Science ®Google Scholar
• Chauret N, Gauthier A, Nicoll-Griffith DA. (1998). Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 26:1–4
   PubMed Web of Science ®Google Scholar
• Critchley DJP, Rance DJ, Beedham C. (1994). Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment. Xenobiotica 24:37--47
   Google Scholar
• Dalvie D, Zhang, C, Chen W, et al. (2010). Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences. Drug Metab Dispos 38:641–54
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. (2011). Increasing recognition of the importance of aldehyde oxidase in drug development and discovery. Drug Met Rev 43:374–86
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. (2012). The role of aldehyde oxidase in drug metabolism. Expert Opin Drug Metab Toxicol 8:487–503
   PubMed Web of Science ®Google Scholar
• Jordan MCG, Rashidi RM, Laljee H, et al. (1999). Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. J Pharm Pharmacol 51:411–18
   PubMed Web of Science ®Google Scholar
• Johnson C, Beedham CS, Stell JGP. (1985). Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochem Pharmacol 34:4251–6
   PubMed Web of Science ®Google Scholar
• Kawashima K, Hosoi K, Naruke T, et al. (1999). Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats. Drug Metab Dispos 27:422–8
   PubMed Web of Science ®Google Scholar
• Kim RB, O'Shea D, Wilkinson GR. (1994). Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Pharmacogenetics 4:162--5
   Google Scholar
• Lake BG, Ball SE, Ka J, et al. (2002). Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica 32:835–47
   PubMed Web of Science ®Google Scholar
• Nirogi R, Kandikere V, Bhyrapuneni G, et al. (2011). Effect of dimethyl sulfoxide on in vitro cytochrome P450 mediated phenacetin O-deethylation in human liver microsomes. Drug Metab Dispos 39:2162–4
   PubMed Web of Science ®Google Scholar
• Obach RS, Huynh P, Allen CM, Beedham C. (2004). Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 44:7–19
   PubMed Web of Science ®Google Scholar
• Obach RS. (2004). Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32:89–97
   PubMed Web of Science ®Google Scholar
• O'Connor D, Jones P, Chambers MS, et al. (2006). Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist. Xenobiotica 36:315–30
   PubMed Web of Science ®Google Scholar
• Panoutsopoulos GI, Kouretas D, Beedham C. (2004). Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes. Chem Res Toxicol 17:1368–76
   PubMed Web of Science ®Google Scholar
• Peter R, Bocker R, Beaune PH, et al. (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 3:566--73
   Google Scholar
• Pryde DC, Dalvie D, Hu Q, et al. (2010). Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53:8441–60
   PubMed Web of Science ®Google Scholar
• Rashidi MR, Smith JA, Clarke SE, Beedham C. (1997). In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit and rat liver. Drug Metab Dispos 25:805–13
   PubMed Web of Science ®Google Scholar
• Sahi J, Kishore KK, Black CB. (2008). Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. Drug met let 2:176–83
   PubMedGoogle Scholar
• Sugihara K, Kitamura S, Tatsumi K. (1996). Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab Dispos 24:199–202
   PubMed Web of Science ®Google Scholar
• Strelevitz TJ, Orozco CC, Obach RS. (2012). Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance. Drug Metab Dispos 40:1441–8
   PubMed Web of Science ®Google Scholar
• Zientek M, Jiang Y, Youdim K, Obach RS. (2010). In vitro--in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab Dispos 38:1322–7
   PubMed Web of Science ®Google Scholar